Intensive care medicine: triage in case of bottlenecks, chronology

SAMS » Ethics » Topics A–Z » Intensive care medicine » Guidelines – chronology

The guidelines «COVID-19 pandemic: triage for intensive-care treatment under resource scarcity» were published on 20 March 2020 by the SAMS, together with the Swiss Society for Intensive Care Medicine (SGI). They will be continuously adapted if experience in practice or new scientific findings so require. On this page you can find all versions in all four languages.

The latest version of the guidelines as well as other relevant documents and background information can be found here.

 

Significant clarifications from version 1 to version 2

The two stages (A and B) defined in the Box on page 4 of the guidelines remain fundamental:

 

Stage A: ICU beds available, but capacity limited
→ Admission triage/resource management through decisions on discontinuation of treatment

 

Stage B: No ICU beds available
→ Admission triage/resource management through decisions on discontinuation of treatment

 

Clarifications

Stage A: New wording for malignant disease: rather than “metastatic malignant disease”, the guidelines now refer to “malignant disease with a life expectancy of less than 12 months”.

 

Stage A: Distinction between existing and newly arising organ failure. The decisive factor is not whether the patient already has an organ failure on admission, but the occurrence of a new significant organ failure.

 

Stages A and B: Refinement of the triage criteria for patients with COPD.

 

 

 

 

 

 

CONTACT

Dr. iur. Thomas Gruberski
Head Department Ethics